C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/74 (2006.01) A61K 31/425 (2006.01) A61K 31/435 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) A61K 31/55 (2006.01) C07D 213/55 (2006.01) C07D 213/56 (2006.01) C07D 213/68 (2006.01) C07D 213/73 (2006.01) C07D 213/75 (2006.01) C07D 277/40 (2006.01) C07D 285/06 (2006.01) C07D 295/155 (2006.01) C07D 295/205 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01) C07D 4
Patent
CA 2242877
Fibrinogen receptor antagonists having formula (I), for example (a), which are useful for inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Des antagonistes du récepteur du fibrinogène ayant la formule (I) par exemple (a), sont utiles pour inhiber la liaison du fibrinogène aux plaquettes sanguines et pour inhiber l'agrégation des plaquettes sanguines.
Askew Benny C.
Brashear Karen M.
Duggan Mark E.
Hartman George D.
Hunt Cecilia A.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1514646